MARKET

SF-PRB

SF-PRB

Stifel Financial Corp
NYSE
23.62
-0.15
-0.63%
Closed 13:20 04/18 EDT
OPEN
23.85
PREV CLOSE
23.77
HIGH
23.93
LOW
23.57
VOLUME
6.89K
TURNOVER
0
52 WEEK HIGH
25.73
52 WEEK LOW
19.82
MARKET CAP
151.17M
P/E (TTM)
5.52
1D
5D
1M
3M
1Y
5Y
UPDATE 1-Adidas surges as strong momentum helps Q1 beat, triggers outlook hike
Adidas shares hit highest level in over two years after better-than-expected quarterly results. German sportswear giant raised 2024 guidance on stronger momentum. Growth driven by strong demand momentum in retro styles and performance categories. Adidas has been undergoing a turnaround after suspending sales of Yeezy sneaker line.
Reuters · 1d ago
UPDATE 2-Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat
Adidas shares surpass two-year high as 'terrace' sneaker trend boosts brand heat. Shares up over 8% on Q1 beat, hiked outlook on strong demand in retro styles. Growth driven by strong demand momentum in "terrace" retro styles, analysts say. German sportswear giant reported quarterly results above expectations and hiked 2024 guidance. Analysts see guidance as conservative.
Reuters · 1d ago
Weekly Report: what happened at SF PRB last week (0408-0412)?
Weekly Report · 3d ago
UPDATE 2-Insurer Bowhead Specialty's profit more than doubled in 2023, IPO filing shows
Insurer Bowhead Specialty's profit more than doubled in 2023, IPO filing shows. U.S. Initial public offering market expected to recover in 2024, after two-year dry spell. Insurance underwriting company's net premiums written up 36.5% to $334.7 million. The company will list on the New York Stock Exchange.
Reuters · 6d ago
BUZZ-Stifel raises PT for U.S. rails on long-term growth prospects
Stifel raises PT for U.S. Rails on long-term growth prospects. Brokerage rates CSX at "buy", UNP and NSC at "hold" Low gas prices have caused a sharp decline in coal demand/carloads - Stifel.
Reuters · 6d ago
BUZZ-Nurix Therapeutics drops after upsized $175 mln stock offering
Nurix Therapeutics Inc's shares down 5.3% at $16.30 premarket after upsized $175 mln stock offering. Biopharma firm Nurix announced 11.7 mln shares to be sold at $15 each. Nurix shares closed up 27% last week.
Reuters · 6d ago
STIFEL FINANCIAL CORP <SF.N>: CITIGROUP RAISES TARGET PRICE TO $80 FROM $74
Reuters · 04/11 10:50
Weekly Report: what happened at SF PRB last week (0401-0405)?
Weekly Report · 04/08 12:28
More
About SF-PRB
Stifel Financial Corp. is a financial holding company. The Company's principal subsidiary is Stifel, Nicolaus & Company, Incorporated, a full-service retail and institutional wealth management and investment banking company. Its segment includes Global Wealth Management, Institutional Group, and others. Its Global Wealth Management segment consists of two businesses, the Private Client Group and Stifel Bancorp. The Private Client Group provides securities brokerage services, including the sale of equities, mutual funds, fixed income products, and insurance, as well as offering banking products to its private clients through its bank subsidiaries, which provide residential, consumer, commercial lending, and FDIC-insured deposit accounts to customers. The Institutional Group segment includes institutional sales and trading. The Other segment includes interest income from stock borrow activities, unallocated interest expense, interest income and gains and losses from investments.

Webull offers Stifel Financial Corp stock information, including NYSE: SF PRB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SF PRB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SF-PRB stock methods without spending real money on the virtual paper trading platform.